“HiberGene is a company that had hit a classic speedbump where it had developed great products but was not seeing the revenues,” CEO David Corr told The Currency last March. With 13 products in the company’s armoury, including a Covid 19/flu combo test, Corr was optimistic that the experienced executive team behind the medical diagnostics firm could turn the business around. In the wings were investors Des and Brendan O’Farrell, brothers from Meath who had made it big in the US, by setting up successful American diagnostic firms Empirical Bioscience and DCN Dx and now wanted to invest in Ireland. The…

Join The Currency

INTRODUCTORY OFFER: Full annual membership for just €200.

Don’t miss out on what is going on with our daily unique stories from our team of skilled journalists and insightful commentators.

Members of The Currency get full access to over 4,000 exclusive interviews, investigations, and analysis, plus over 460 podcasts.

Annual membership is just €200 for the first year, a saving of €100.

Or try The Currency for the first month for a special introductory rate of €5, a saving of €20.

Cancel at any time.

To become a member today click here.